Apollo Hospitals Enterprise Limited (APOLLOHOSP) Stock Statistics & Valuation Metrics

Apollo Hospitals Enterprise Limited has a market cap or net worth of ₹1.27T. The enterprise value is ₹1.29T.

Apollo Hospitals Enterprise Limited has 143,784,650 shares outstanding. The number of shares has decreased by -2.65% in one year.

Apollo Hospitals Enterprise Limited’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 11.40%.

The current PE Ratio of Apollo Hospitals Enterprise Limited is 65.5. Apollo Hospitals Enterprise Limited’s PEG ratio is 1.60.

In the last 12 months, Apollo Hospitals Enterprise Limited had revenue of 252.28B and earned 19.42B in profits. Earnings per share was 135.04.

In the last 12 months, operating cash flow was 13.25B and capital expenditures -7.07B, giving a free cash flow of 6.19B billion.

Apollo Hospitals Enterprise Limited pays an annual dividend of ₹10, resulting in a dividend yield of 0.27%

Apollo Hospitals Enterprise Limited upcoming earnings date is Aug 7, 2026, TBA (Confirmed).

Apollo Hospitals Enterprise Limited as a current ratio of 1.06, with Debt / Equity ratio of 89.59%

In the past 12 months, Apollo Hospitals Enterprise Limited has paid 6.58B in taxes.

Apollo Hospitals Enterprise Limited EV to EBITDA ratio is 28.61, with an EV/FCF ratio of 160.14.

Apollo Hospitals Enterprise Limited has ₹21.33B in cash and marketable securities with ₹84.93B in debt, giving a net cash position of -₹63.60B billion.

Gross margin is 37.49%, with operating margin of 11.47%, and net profit margin of 7.70%.

The average price target for Apollo Hospitals Enterprise Limited is ₹9,700.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy